The immune profiling of tumour microenvironment upon Y-90 treatment in HCC patients
Yttrium-90 (Y-90) radioembolization serves as an important therapy for hepatocellular carcinoma (HCC) patients to downsize tumours and delay disease progression. However, its immunological impact on the tumour micronenvironment requires further understanding to improve its clinical efficacy. This st...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2017
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/70823 |